Akums Drugs & Pharmaceuticals Ltd. - Research Center
544222 AKUMS Group (B) BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Ratio
|
Ratios
(Rs crore)
| Mar ' 24 | Mar ' 23 | ||||
|---|---|---|---|---|---|
| Per share ratios | |||||
| Adjusted EPS (Rs) | -10.21 | 18.87 | |||
| Adjusted cash EPS (Rs) | -7.92 | 20.97 | |||
| Reported EPS (Rs) | -11.56 | 8.77 | |||
| Reported cash EPS (Rs) | -9.28 | 10.86 | |||
| Dividend per share | - | - | |||
| Operating profit per share (Rs) | -8.85 | 16.91 | |||
| Book value (excl rev res) per share EPS (Rs) | 10.06 | 21.77 | |||
| Book value (incl rev res) per share EPS (Rs) | 10.06 | 21.77 | |||
| Net operating income per share EPS (Rs) | 100.94 | 89.95 | |||
| Free reserves per share EPS (Rs) | - | - | |||
| Profitability ratios | |||||
| Operating margin (%) | -8.77 | 18.79 | |||
| Gross profit margin (%) | -11.03 | 16.46 | |||
| Net profit margin (%) | -11.45 | 9.74 | |||
| Adjusted cash margin (%) | -7.36 | 21.68 | |||
| Adjusted return on net worth (%) | -101.51 | 86.66 | |||
| Reported return on net worth (%) | -114.99 | 40.26 | |||
| Return on long term funds (%) | -40.89 | 92.39 | |||
| Leverage ratios | |||||
| Long term debt / Equity | 0.10 | 0.07 | |||
| Total debt/equity | 1.57 | 0.46 | |||
| Owners fund as % of total source | 38.86 | 68.14 | |||
| Fixed assets turnover ratio | 3.49 | 3.37 | |||
| Liquidity ratios | |||||
| Current ratio | 0.94 | 1.02 | |||
| Current ratio (inc. st loans) | 0.75 | 0.87 | |||
| Quick ratio | 0.85 | 0.88 | |||
| Inventory turnover ratio | 3.90 | 2.82 | |||
| Payout ratios | |||||
| Dividend payout ratio (net profit) | - | - | |||
| Dividend payout ratio (cash profit) | - | - | |||
| Earning retention ratio | 100.00 | 100.00 | |||
| Cash earnings retention ratio | - | 100.00 | |||
| Coverage ratios | |||||
| Adjusted cash flow time total debt | - | 0.48 | |||
| Financial charges coverage ratio | -1.78 | 25.66 | |||
| Fin. charges cov.ratio (post tax) | -6.25 | 12.80 | |||
| Component ratios | |||||
| Material cost component (% earnings) | 61.40 | 62.79 | |||
| Selling cost Component | - | - | |||
| Exports as percent of total sales | 6.41 | - | |||
| Import comp. in raw mat. consumed | - | - | |||
| Long term assets / total Assets | 0.22 | 0.20 | |||
| Bonus component in equity capital (%) | 49.99 | - | |||
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis